<DOC>
	<DOCNO>NCT01923376</DOCNO>
	<brief_summary>The purpose study evaluate whether use polyethylene glycol superior safe treat hepatic encephalopathy compare lactulose also determine treatment polyethylene glycol reduce duration hospital stay .</brief_summary>
	<brief_title>Hepatic Encephalopathy : Lactulose Polyethylene Glycol ( H.E.L.P . )</brief_title>
	<detailed_description>Hepatic encephalopathy occurrence alter level consciousness result cirrhosis liver failure . Main treatment goal hepatic encephalopathy eliminate precipitate factor decrease circulate ammonia level . Current standard treating HE treatment Lactulose . Lactulose metabolize colonic bacteria byproduct cause catharsis reduces pH , thereby inhibit ammonia absorption . However , limited evidence available demonstrate efficacy . Studies animal model suggest polyethylene glycol 3350-electrolyte solution ( GOLYTELY ) effective clearing gut bacteria reduce ammoniagenesis colon . Recently publish study Robert Rahimi , University Texas Southwestern Medical Center find polyethylene glycol effective improving HE first 24 hour compare lactulose also may reduce duration hospital stay .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Age 18 80 Male female race ethnicity Cirrhosis cause Any grade hepatic encephalopathy ( 14 ) Representatives willing comply protocol procedure understand , sign date inform consent document authorize access protect health information subject 's behalf Acute liver failure Prisoners Structural brain lesion ( indicated CT confirm neurological exam ) Other cause alter mental status Previous use rifaximin neomycin within last 7 day Pregnancy Serum Na &lt; 125 MEq/liter Receiving 1 dose ( 30 cc ) lactulose prior enrollment Uncontrolled infection hemodynamic instability require vasopressor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>hepatic encephalopathy</keyword>
	<keyword>hepatic coma</keyword>
	<keyword>HE</keyword>
	<keyword>PSE</keyword>
	<keyword>lactulose</keyword>
	<keyword>golytely</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>Hepatic Insufficiency</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>Fibrosis</keyword>
	<keyword>Brain Damage , Chronic</keyword>
	<keyword>Delirium</keyword>
	<keyword>Encephalitis</keyword>
	<keyword>Neurotoxicity Syndromes</keyword>
	<keyword>Liver Failure</keyword>
	<keyword>Liver Diseases</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Brain Diseases , Metabolic</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Confusion</keyword>
	<keyword>Neurobehavioral Manifestations</keyword>
	<keyword>Neurologic Manifestations</keyword>
	<keyword>Signs Symptoms</keyword>
	<keyword>Delirium , Dementia , Amnestic , Cognitive Disorders</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Central Nervous System Viral Diseases</keyword>
	<keyword>Virus Diseases</keyword>
	<keyword>Central Nervous System Infections</keyword>
	<keyword>Poisoning</keyword>
	<keyword>Substance-Related Disorders</keyword>
	<keyword>Citric Acid</keyword>
</DOC>